市場調査レポート

商品コード

1461248

オキシコドン塩酸塩市場の評価：純度・タイプ・形態・用途・地域別の機会および予測 (2017-2031年)

Oxycodone Hydrochloride Market Assessment, By Purity, By Type, By Form, By Application, By Region, Opportunities and Forecast, 2017-2031F

出版日: 2024年04月09日 | 発行: Market Xcel - Markets and Data

| ページ情報: 英文 238 Pages | 納期: 3～5営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　詳細はお問い合わせください。

価格

PDF & Excel Printable (Single User License)

USD 4,500 707,130円

レポートPDFを1名の方がご利用頂けるライセンスです。レポートPDFのパスワード保護はありません。PDF内のテキスト等のコピー＆ペーストは可能です。印刷は無制限で可能です。Excelのデータがライセンスに含まれています。

PDF & Excel Printable (Corporate License)

USD 5,700 895,698円

レポートPDFを企業の１カ国の拠点のすべての方がご利用頂けるライセンスです。レポートPDFのパスワード保護はありません。PDF内のテキスト等のコピー＆ペーストは可能ですが、企業内部での利用に限定されます。ご利用に際しては、あらかじめ出版社の許諾を得る必要があります。詳細はお問合せください。印刷は可能です。Excelのデータがライセンスに含まれています。

PDF & Excel Printable (Custom Research License)

USD 8,200 1,288,548円

レポートPDFを企業の１カ国の拠点のすべての方がご利用頂けるライセンスです。レポートPDFのパスワード保護はありません。PDF内のテキスト等のコピー＆ペーストは可能です。印刷は無制限で可能です。Excelのデータがライセンスに含まれています。アナリストアワー100時間が含まれており、レポートのカスタマイズなどにご利用いただけます。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=157.14円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

世界のオキシコドン塩酸塩の市場規模は、2023年の4億2,150万米ドルから、2024年から2031年の予測期間中は5.1%のCAGRで推移し、2031年には6億2,751万米ドルの規模に成長すると予測されています。

癌の有病率の急増や、専門クリニック、病院、外来手術センターなどのヘルスケア部門からのニーズの高まりなどの要因が、オキシコドン塩酸塩の採用を加速させており、それが市場の成長を後押ししています。半合成オピオイドであるオキシコドン塩酸塩とオキシモルフォンのメチルエーテルには鎮咳・鎮痛作用があります。効果的な疼痛管理ソリューションへの嗜好の高まりが市場成長の主要な促進要因のひとつです。

市場の拡大を支えているのは、高齢者人口の増加による重度の疼痛事例の増加です。例えば、World Health Organization (WHO) の推計によると、2030年までに全世界の6人に1人が60歳以上になるといわれており、2050年には、60歳以上の人口は約21億人に達すると考えられています。この増加がオキシコドン塩酸塩の必要性を高めると思われます。オキシコドン塩酸塩は急性の激しい疼痛を和らげるために使用され、高齢者層はさまざまな疼痛に関連した疾患に罹患しやすくなるためです。そのため、製品に対する需要が高まり、オキシコドン塩酸塩の世界市場規模が拡大します。

オキシコドン塩酸塩は、中程度の効力のオピオイド鎮痛薬で、重度から中程度の疼痛を和らげるのに役立ち、1モル当量の塩酸とオキシコドンの反応によって得られます。オキシコドンは中枢神経系に存在するミュー受容体と結合し、内因性オピエートの作用を模倣します。この化学物質は、オキシコドン塩酸塩カプセル、ペルコダン、ロキシーボンドなど、さまざまな医薬品の有効成分として使用されています。このため、この化学薬品に対する需要は医薬品製造セクターから高まっており、市場の拡大を支えています。

癌の有病率の増加が世界のオキシコドン塩酸塩市場の成長を支える：

従来の治療にオキシコドン塩酸塩を加えることで、従来の治療単独と比較して、放射線誘発性口腔粘膜炎の疼痛を効果的に抑えることができます。この併用療法はまた、患者の生活の質を高めるとともに、食習慣を大幅に改善するのにも役立ちます。オキシコドン塩酸塩は脊髄や脳のオピオイド受容体に強い親和性を持つことで知られており、骨転移に対して効果的な鎮痛効果を発揮します。多くの臨床医は、悪性腫瘍の骨転移による中等度から重度の疼痛を治療するために、オキシコドン塩酸塩と放射線治療を併用してきました。この併用により、長期および短期の鎮痛効果が得られています。

当レポートでは、世界のオキシコドン塩酸塩の市場を調査し、市場の定義と概要、市場規模の推移・予測、各種区分・地域別の詳細分析、産業構造、市場成長への影響因子の分析、ケーススタディ、競合情勢、主要企業のプロファイルなどをまとめています。

List of Tables

Table 1. Pricing Analysis of Products from Key Players
Table 2. Competition Matrix of Top 5 Market Leaders
Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

Figure 1.Global Oxycodone Hydrochloride Market, By Value, In USD Million, 2017-2031F
Figure 2.Global Oxycodone Hydrochloride Market, By Volume, In Kilotons, 2017-2031F
Figure 3.Global Oxycodone Hydrochloride Market Share (%), By Purity, 2017-2031F
Figure 4.Global Oxycodone Hydrochloride Market Share (%), By Type, 2017-2031F
Figure 5.Global Oxycodone Hydrochloride Market Share (%), By Form, 2017-2031F
Figure 6.Global Oxycodone Hydrochloride Market Share (%), By Application, 2017-2031F
Figure 7.Global Oxycodone Hydrochloride Market Share (%), By Region, 2017-2031F
Figure 8.North America Oxycodone Hydrochloride Market, By Value, In USD Million, 2017-2031F
Figure 9.North America Oxycodone Hydrochloride Market, By Volume, In Kilotons, 2017-2031F
Figure 10.North America Oxycodone Hydrochloride Market Share (%), By Purity, 2017-2031F
Figure 11.North America Oxycodone Hydrochloride Market Share (%), By Type, 2017-2031F
Figure 12.North America Oxycodone Hydrochloride Market Share (%), By Form, 2017-2031F
Figure 13.North America Oxycodone Hydrochloride Market Share (%), By Application, 2017-2031F
Figure 14.North America Oxycodone Hydrochloride Market Share (%), By Country, 2017-2031F
Figure 15.United States Oxycodone Hydrochloride Market, By Value, In USD Million, 2017-2031F
Figure 16.United States Oxycodone Hydrochloride Market, By Volume, In Kilotons, 2017-2031F
Figure 17.United States Oxycodone Hydrochloride Market Share (%), By Purity, 2017-2031F
Figure 18.United States Oxycodone Hydrochloride Market Share (%), By Type, 2017-2031F
Figure 19.United States Oxycodone Hydrochloride Market Share (%), By Form, 2017-2031F
Figure 20.United States Oxycodone Hydrochloride Market Share (%), By Application, 2017-2031F
Figure 21.Canada Oxycodone Hydrochloride Market, By Value, In USD Million, 2017-2031F
Figure 22.Canada Oxycodone Hydrochloride Market, By Volume, In Kilotons, 2017-2031F
Figure 23.Canada Oxycodone Hydrochloride Market Share (%), By Purity, 2017-2031F
Figure 24.Canada Oxycodone Hydrochloride Market Share (%), By Type, 2017-2031F
Figure 25.Canada Oxycodone Hydrochloride Market Share (%), By Form, 2017-2031F
Figure 26.Canada Oxycodone Hydrochloride Market Share (%), By Application, 2017-2031F
Figure 27.Mexico Oxycodone Hydrochloride Market, By Value, In USD Million, 2017-2031F
Figure 28.Mexico Oxycodone Hydrochloride Market, By Volume, In Kilotons, 2017-2031F
Figure 29.Mexico Oxycodone Hydrochloride Market Share (%), By Purity, 2017-2031F
Figure 30.Mexico Oxycodone Hydrochloride Market Share (%), By Type, 2017-2031F
Figure 31.Mexico Oxycodone Hydrochloride Market Share (%), By Form, 2017-2031F
Figure 32.Mexico Oxycodone Hydrochloride Market Share (%), By Application, 2017-2031F
Figure 33.Europe Oxycodone Hydrochloride Market, By Value, In USD Million, 2017-2031F
Figure 34.Europe Oxycodone Hydrochloride Market, By Volume, In Kilotons, 2017-2031F
Figure 35.Europe Oxycodone Hydrochloride Market Share (%), By Purity, 2017-2031F
Figure 36.Europe Oxycodone Hydrochloride Market Share (%), By Type, 2017-2031F
Figure 37.Europe Oxycodone Hydrochloride Market Share (%), By Form, 2017-2031F
Figure 38.Europe Oxycodone Hydrochloride Market Share (%), By Application, 2017-2031F
Figure 39.Europe Oxycodone Hydrochloride Market Share (%), By Country, 2017-2031F
Figure 40.Germany Oxycodone Hydrochloride Market, By Value, In USD Million, 2017-2031F
Figure 41.Germany Oxycodone Hydrochloride Market, By Volume, In Kilotons, 2017-2031F
Figure 42.Germany Oxycodone Hydrochloride Market Share (%), By Purity, 2017-2031F
Figure 43.Germany Oxycodone Hydrochloride Market Share (%), By Type, 2017-2031F
Figure 44.Germany Oxycodone Hydrochloride Market Share (%), By Form, 2017-2031F
Figure 45.Germany Oxycodone Hydrochloride Market Share (%), By Application, 2017-2031F
Figure 46.France Oxycodone Hydrochloride Market, By Value, In USD Million, 2017-2031F
Figure 47.France Oxycodone Hydrochloride Market, By Volume, In Kilotons, 2017-2031F
Figure 48.France Oxycodone Hydrochloride Market Share (%), By Purity, 2017-2031F
Figure 49.France Oxycodone Hydrochloride Market Share (%), By Type, 2017-2031F
Figure 50.France Oxycodone Hydrochloride Market Share (%), By Form, 2017-2031F
Figure 51.France Oxycodone Hydrochloride Market Share (%), By Application, 2017-2031F
Figure 52.Italy Oxycodone Hydrochloride Market, By Value, In USD Million, 2017-2031F
Figure 53.Italy Oxycodone Hydrochloride Market, By Volume, In Kilotons, 2017-2031F
Figure 54.Italy Oxycodone Hydrochloride Market Share (%), By Purity, 2017-2031F
Figure 55.Italy Oxycodone Hydrochloride Market Share (%), By Type, 2017-2031F
Figure 56.Italy Oxycodone Hydrochloride Market Share (%), By Form, 2017-2031F
Figure 57.Italy Oxycodone Hydrochloride Market Share (%), By Application, 2017-2031F
Figure 58.United Kingdom Oxycodone Hydrochloride Market, By Value, In USD Million, 2017-2031F
Figure 59.United Kingdom Oxycodone Hydrochloride Market, By Volume, In Kilotons, 2017-2031F
Figure 60.United Kingdom Oxycodone Hydrochloride Market Share (%), By Purity, 2017-2031F
Figure 61.United Kingdom Oxycodone Hydrochloride Market Share (%), By Type, 2017-2031F
Figure 62.United Kingdom Oxycodone Hydrochloride Market Share (%), By Form, 2017-2031F
Figure 63.United Kingdom Oxycodone Hydrochloride Market Share (%), By Application, 2017-2031F
Figure 64.Russia Oxycodone Hydrochloride Market, By Value, In USD Million, 2017-2031F
Figure 65.Russia Oxycodone Hydrochloride Market, By Volume, In Kilotons, 2017-2031F
Figure 66.Russia Oxycodone Hydrochloride Market Share (%), By Purity, 2017-2031F
Figure 67.Russia Oxycodone Hydrochloride Market Share (%), By Type, 2017-2031F
Figure 68.Russia Oxycodone Hydrochloride Market Share (%), By Form, 2017-2031F
Figure 69.Russia Oxycodone Hydrochloride Market Share (%), By Application, 2017-2031F
Figure 70.Netherlands Oxycodone Hydrochloride Market, By Value, In USD Million, 2017-2031F
Figure 71.Netherlands Oxycodone Hydrochloride Market, By Volume, In Kilotons, 2017-2031F
Figure 72.Netherlands Oxycodone Hydrochloride Market Share (%), By Purity, 2017-2031F
Figure 73.Netherlands Oxycodone Hydrochloride Market Share (%), By Type, 2017-2031F
Figure 74.Netherlands Oxycodone Hydrochloride Market Share (%), By Form, 2017-2031F
Figure 75.Netherlands Oxycodone Hydrochloride Market Share (%), By Application, 2017-2031F
Figure 76.Spain Oxycodone Hydrochloride Market, By Value, In USD Million, 2017-2031F
Figure 77.Spain Oxycodone Hydrochloride Market, By Volume, In Kilotons, 2017-2031F
Figure 78.Spain Oxycodone Hydrochloride Market Share (%), By Purity, 2017-2031F
Figure 79.Spain Oxycodone Hydrochloride Market Share (%), By Type, 2017-2031F
Figure 80.Spain Oxycodone Hydrochloride Market Share (%), By Form, 2017-2031F
Figure 81.Spain Oxycodone Hydrochloride Market Share (%), By Application, 2017-2031F
Figure 82.Turkey Oxycodone Hydrochloride Market, By Value, In USD Million, 2017-2031F
Figure 83.Turkey Oxycodone Hydrochloride Market, By Volume, In Kilotons, 2017-2031F
Figure 84.Turkey Oxycodone Hydrochloride Market Share (%), By Purity, 2017-2031F
Figure 85.Turkey Oxycodone Hydrochloride Market Share (%), By Type, 2017-2031F
Figure 86.Turkey Oxycodone Hydrochloride Market Share (%), By Form, 2017-2031F
Figure 87.Turkey Oxycodone Hydrochloride Market Share (%), By Application, 2017-2031F
Figure 88.Poland Oxycodone Hydrochloride Market, By Value, In USD Million, 2017-2031F
Figure 89.Poland Oxycodone Hydrochloride Market, By Volume, In Kilotons, 2017-2031F
Figure 90.Poland Oxycodone Hydrochloride Market Share (%), By Purity, 2017-2031F
Figure 91.Poland Oxycodone Hydrochloride Market Share (%), By Type, 2017-2031F
Figure 92.Poland Oxycodone Hydrochloride Market Share (%), By Form, 2017-2031F
Figure 93.Poland Oxycodone Hydrochloride Market Share (%), By Application, 2017-2031F
Figure 94.South America Oxycodone Hydrochloride Market, By Value, In USD Million, 2017-2031F
Figure 95.South America Oxycodone Hydrochloride Market, By Volume, In Kilotons, 2017-2031F
Figure 96.South America Oxycodone Hydrochloride Market Share (%), By Purity, 2017-2031F
Figure 97.South America Oxycodone Hydrochloride Market Share (%), By Type, 2017-2031F
Figure 98.South America Oxycodone Hydrochloride Market Share (%), By Form, 2017-2031F
Figure 99.South America Oxycodone Hydrochloride Market Share (%), By Application, 2017-2031F
Figure 100.South America Oxycodone Hydrochloride Market Share (%), By Country, 2017-2031F
Figure 101.Brazil Oxycodone Hydrochloride Market, By Value, In USD Million, 2017-2031F
Figure 102.Brazil Oxycodone Hydrochloride Market, By Volume, In Kilotons, 2017-2031F
Figure 103.Brazil Oxycodone Hydrochloride Market Share (%), By Purity, 2017-2031F
Figure 104.Brazil Oxycodone Hydrochloride Market Share (%), By Type, 2017-2031F
Figure 105.Brazil Oxycodone Hydrochloride Market Share (%), By Form, 2017-2031F
Figure 106.Brazil Oxycodone Hydrochloride Market Share (%), By Application, 2017-2031F
Figure 107.Argentina Oxycodone Hydrochloride Market, By Value, In USD Million, 2017-2031F
Figure 108.Argentina Oxycodone Hydrochloride Market, By Volume, In Kilotons, 2017-2031F
Figure 109.Argentina Oxycodone Hydrochloride Market Share (%), By Purity, 2017-2031F
Figure 110.Argentina Oxycodone Hydrochloride Market Share (%), By Type, 2017-2031F
Figure 111.Argentina Oxycodone Hydrochloride Market Share (%), By Form, 2017-2031F
Figure 112.Argentina Oxycodone Hydrochloride Market Share (%), By Application, 2017-2031F
Figure 113.Asia-Pacific Oxycodone Hydrochloride Market, By Value, In USD Million, 2017-2031F
Figure 114.Asia-Pacific Oxycodone Hydrochloride Market, By Volume, In Kilotons, 2017-2031F
Figure 115.Asia-Pacific Oxycodone Hydrochloride Market Share (%), By Purity, 2017-2031F
Figure 116.Asia-Pacific Oxycodone Hydrochloride Market Share (%), By Type, 2017-2031F
Figure 117.Asia-Pacific Oxycodone Hydrochloride Market Share (%), By Form, 2017-2031F
Figure 118.Asia-Pacific Oxycodone Hydrochloride Market Share (%), By Application, 2017-2031F
Figure 119.Asia-Pacific Oxycodone Hydrochloride Market Share (%), By Country, 2017-2031F
Figure 120.India Oxycodone Hydrochloride Market, By Value, In USD Million, 2017-2031F
Figure 121.India Oxycodone Hydrochloride Market, By Volume, In Kilotons, 2017-2031F
Figure 122.India Oxycodone Hydrochloride Market Share (%), By Purity, 2017-2031F
Figure 123.India Oxycodone Hydrochloride Market Share (%), By Type, 2017-2031F
Figure 124.India Oxycodone Hydrochloride Market Share (%), By Form, 2017-2031F
Figure 125.India Oxycodone Hydrochloride Market Share (%), By Application, 2017-2031F
Figure 126.China Oxycodone Hydrochloride Market, By Value, In USD Million, 2017-2031F
Figure 127.China Oxycodone Hydrochloride Market, By Volume, In Kilotons, 2017-2031F
Figure 128.China Oxycodone Hydrochloride Market Share (%), By Purity, 2017-2031F
Figure 129.China Oxycodone Hydrochloride Market Share (%), By Type, 2017-2031F
Figure 130.China Oxycodone Hydrochloride Market Share (%), By Form, 2017-2031F
Figure 131.China Oxycodone Hydrochloride Market Share (%), By Application, 2017-2031F
Figure 132.Japan Oxycodone Hydrochloride Market, By Value, In USD Million, 2017-2031F
Figure 133.Japan Oxycodone Hydrochloride Market, By Volume, In Kilotons, 2017-2031F
Figure 134.Japan Oxycodone Hydrochloride Market Share (%), By Purity, 2017-2031F
Figure 135.Japan Oxycodone Hydrochloride Market Share (%), By Type, 2017-2031F
Figure 136.Japan Oxycodone Hydrochloride Market Share (%), By Form, 2017-2031F
Figure 137.Japan Oxycodone Hydrochloride Market Share (%), By Application, 2017-2031F
Figure 138.Australia Oxycodone Hydrochloride Market, By Value, In USD Million, 2017-2031F
Figure 139.Australia Oxycodone Hydrochloride Market, By Volume, In Kilotons, 2017-2031F
Figure 140.Australia Oxycodone Hydrochloride Market Share (%), By Purity, 2017-2031F
Figure 141.Australia Oxycodone Hydrochloride Market Share (%), By Type, 2017-2031F
Figure 142.Australia Oxycodone Hydrochloride Market Share (%), By Form, 2017-2031F
Figure 143.Australia Oxycodone Hydrochloride Market Share (%), By Application, 2017-2031F
Figure 144.Vietnam Oxycodone Hydrochloride Market, By Value, In USD Million, 2017-2031F
Figure 145.Vietnam Oxycodone Hydrochloride Market, By Volume, In Kilotons, 2017-2031F
Figure 146.Vietnam Oxycodone Hydrochloride Market Share (%), By Purity, 2017-2031F
Figure 147.Vietnam Oxycodone Hydrochloride Market Share (%), By Type, 2017-2031F
Figure 148.Vietnam Oxycodone Hydrochloride Market Share (%), By Form, 2017-2031F
Figure 149.Vietnam Oxycodone Hydrochloride Market Share (%), By Application, 2017-2031F
Figure 150.South Korea Oxycodone Hydrochloride Market, By Value, In USD Million, 2017-2031F
Figure 151.South Korea Oxycodone Hydrochloride Market, By Volume, In Kilotons, 2017-2031F
Figure 152.South Korea Oxycodone Hydrochloride Market Share (%), By Purity, 2017-2031F
Figure 153.South Korea Oxycodone Hydrochloride Market Share (%), By Type, 2017-2031F
Figure 154.South Korea Oxycodone Hydrochloride Market Share (%), By Form, 2017-2031F
Figure 155.South Korea Oxycodone Hydrochloride Market Share (%), By Application, 2017-2031F
Figure 156.Indonesia Oxycodone Hydrochloride Market, By Value, In USD Million, 2017-2031F
Figure 157.Indonesia Oxycodone Hydrochloride Market, By Volume, In Kilotons, 2017-2031F
Figure 158.Indonesia Oxycodone Hydrochloride Market Share (%), By Purity, 2017-2031F
Figure 159.Indonesia Oxycodone Hydrochloride Market Share (%), By Type, 2017-2031F
Figure 160.Indonesia Oxycodone Hydrochloride Market Share (%), By Form, 2017-2031F
Figure 161.Indonesia Oxycodone Hydrochloride Market Share (%), By Application, 2017-2031F
Figure 162.Philippines Oxycodone Hydrochloride Market, By Value, In USD Million, 2017-2031F
Figure 163.Philippines Oxycodone Hydrochloride Market, By Volume, In Kilotons, 2017-2031F
Figure 164.Philippines Oxycodone Hydrochloride Market Share (%), By Purity, 2017-2031F
Figure 165.Philippines Oxycodone Hydrochloride Market Share (%), By Type, 2017-2031F
Figure 166.Philippines Oxycodone Hydrochloride Market Share (%), By Form, 2017-2031F
Figure 167.Philippines Oxycodone Hydrochloride Market Share (%), By Application, 2017-2031F
Figure 168.Middle East & Africa Oxycodone Hydrochloride Market, By Value, In USD Million, 2017-2031F
Figure 169.Middle East & Africa Oxycodone Hydrochloride Market, By Volume, In Kilotons, 2017-2031F
Figure 170.Middle East & Africa Oxycodone Hydrochloride Market Share (%), By Purity, 2017-2031F
Figure 171.Middle East & Africa Oxycodone Hydrochloride Market Share (%), By Type, 2017-2031F
Figure 172.Middle East & Africa Oxycodone Hydrochloride Market Share (%), By Form, 2017-2031F
Figure 173.Middle East & Africa Oxycodone Hydrochloride Market Share (%), By Application, 2017-2031F
Figure 174.Middle East & Africa Oxycodone Hydrochloride Market Share (%), By Country, 2017-2031F
Figure 175.Saudi Arabia Oxycodone Hydrochloride Market, By Value, In USD Million, 2017-2031F
Figure 176.Saudi Arabia Oxycodone Hydrochloride Market, By Volume, In Kilotons, 2017-2031F
Figure 177.Saudi Arabia Oxycodone Hydrochloride Market Share (%), By Purity, 2017-2031F
Figure 178.Saudi Arabia Oxycodone Hydrochloride Market Share (%), By Type, 2017-2031F
Figure 179.Saudi Arabia Oxycodone Hydrochloride Market Share (%), By Form, 2017-2031F
Figure 180.Saudi Arabia Oxycodone Hydrochloride Market Share (%), By Application, 2017-2031F
Figure 181.UAE Oxycodone Hydrochloride Market, By Value, In USD Million, 2017-2031F
Figure 182.UAE Oxycodone Hydrochloride Market, By Volume, In Kilotons, 2017-2031F
Figure 183.UAE Oxycodone Hydrochloride Market Share (%), By Purity, 2017-2031F
Figure 184.UAE Oxycodone Hydrochloride Market Share (%), By Type, 2017-2031F
Figure 185.UAE Oxycodone Hydrochloride Market Share (%), By Form, 2017-2031F
Figure 186.UAE Oxycodone Hydrochloride Market Share (%), By Application, 2017-2031F
Figure 187.South Africa Oxycodone Hydrochloride Market, By Value, In USD Million, 2017-2031F
Figure 188.South Africa Oxycodone Hydrochloride Market, By Volume, In Kilotons, 2017-2031F
Figure 189.South Africa Oxycodone Hydrochloride Market Share (%), By Purity, 2017-2031F
Figure 190.South Africa Oxycodone Hydrochloride Market Share (%), By Type, 2017-2031F
Figure 191.South Africa Oxycodone Hydrochloride Market Share (%), By Form, 2017-2031F
Figure 192.South Africa Oxycodone Hydrochloride Market Share (%), By Application, 2017-2031F
Figure 193.By Purity Map-Market Size (USD Million) & Growth Rate (%), 2023
Figure 194.By Type Map-Market Size (USD Million) & Growth Rate (%), 2023
Figure 195.By Form Map-Market Size (USD Million) & Growth Rate (%), 2023
Figure 196.By Application Map-Market Size (USD Million) & Growth Rate (%), 2023
Figure 197.By Region Map-Market Size (USD Million) & Growth Rate (%), 2023

Product Code: MX11249

Global oxycodone hydrochloride market is projected to witness a CAGR of 5.1% during the forecast period 2024-2031, growing from USD 421.5 million in 2023 to USD 627.51 million in 2031F. The key factors, such as the surging prevalence of cancer and rising requirements by the healthcare sectors, including specialty clinics, hospitals, and ambulatory surgery centers, are accelerating the adoption of oxycodone hydrochloride, which, in turn, is boosting market growth. The hydrochloride salt of oxycodone, a semisynthetic opioid, and methyl ether of oxymorphone have antitussive and analgesic properties. The increasing preference for effective pain management solutions is one of the major significant drivers for market growth.

The market expansion is supported by the increasing old-age population, resulting in higher cases of severe pain. For instance, according to the World Health Organization (WHO) estimates, one in six individuals living across the world will be sixty years or older by the year 2030. By 2050, the population aged sixty and older will be approximately 2.1 billion. This increase will bolster the requirement for oxycodone hydrochloride as it is used for relieving acute and severe pain and the older population is more susceptible to suffering from various pain-related disorders. Thus, propelling the demand for the product and augmenting the global oxycodone hydrochloride market size.

Oxycodone hydrochloride, a moderately potent opioid analgesic aid in relieving severe to moderate pain and is obtained by the reaction of one molar equivalent of hydrochloric acid and oxycodone. The oxycodone binds with the mu-receptors present in the central nervous system and mimics the effects of endogenous opiates. The chemical is used as an active ingredient in various drugs including oxycodone hydrochloride capsules, Percodan, and Roxybond among others. Due to this, the demand for the chemical is rising from the medicine manufacturing sector, thus supporting the expansion of the market.

Increasing Prevalence of Cancer Supports Global Oxycodone Hydrochloride Market Growth

The addition of oxycodone hydrochloride to conventional therapy aids in effectively controlling the pain from radiation-induced oral mucositis as compared to conventional therapy alone. The combination also helps in significantly improving eating habits along with enhancing the quality of life of patients. Oxycodone hydrochloride is known for having a strong affinity for opioid receptors in the spinal cord and brain, allowing it to deliver effective analgesic effects on bone metastases. Many clinicians have combined oxycodone hydrochloride and radiotherapy for treating moderate to severe pain caused due to bone metastases of malignant tumors. This combination has aided them in achieving a combination of long-term and short-term analgesic effects.

For instance, according to the estimates of CONQUER CANCER (The ASCO Foundation), neck and head cancer accounts for approximately 4% of all cancer cases in the United States. It was estimated that in 2023, 66,930 individuals living in the United States will be diagnosed with neck and head cancers. The rising cases of neck and head cancer in various regions across the globe are therefore propelling the requirement for oxycodone hydrochloride. The administration of prolonged-release tablets is derived from this chemical during radiotherapy, effectively reducing the pain that is caused due to radiation-induced oral mucositis for patients suffering from neck and head cancer. Thus, boosting the requirement for oxycodone hydrochloride and supporting the growth of the market.

Rising Number of Surgeries Boost Global Oxycodone Hydrochloride Market Demand

The mechanism of action of oxycodone is similar to that of the other opioids which includes binding to a receptor, inhibiting hyperpolarization of neurons and adenylyl-cyclase, and reducing impulsiveness. Oxycodone hydrochloride is also used as a preemptive analgesia in various gynecological procedures such as gynecological laparoscopic surgery. Oxycodone hydrochloride is an opioid receptor agonist that is mixed-type and has agonistic effects on both μ and κ receptors. It primarily works for the smooth muscles and central nervous system, allowing the effective treatment of visceral pain as compared to other potent opioids. As a result, the adoption of oxycodone hydrochloride is increasing in surgeries.

For instance, according to the estimates of the Lancet Commission on global surgery, approximately 5,000 surgeries per 100,000 population, per year are required. The estimations show that in India, 3,646 surgeries are required per year, per 100,000 population. Of these 13% are ophthalmological surgeries, 20% are gynecological and obstetric surgeries, and 26% are general surgical procedures. This increase is augmenting the requirement for oxycodone hydrochloride as it is used for pain management in moderate and minor surgeries and postoperative pain. Due to such applications and advantages offered by the chemical, the demand for oxycodone hydrochloride is increasing, supporting the expansion of the market.

North America Holds a Significant Share of the Market

The increasing prevalence of head and neck cancer in the region and the surging requirement for different surgical procedures are major factors supporting the growth of the North America oxycodone hydrochloride market. The augmenting consumption of prescription drugs in the region for effectively managing pain caused by various conditions such as cancer and neuralgia is another major factor propelling the requirement for oxycodone hydrochloride in North America. Additionally, the Food and Drug Administration (FDA) has also approved various prescription drugs that use oxycodone hydrochloride for pain management. The growing requirement for surgical procedures is also boosting the requirement for oxycodone hydrochloride as it is deployed for treating postoperative pain. For instance, according to the estimates of Johns Hopkins Medicine, the most common surgical operations conducted in the United States include appendectomy, breast biopsy, coronary artery bypass, and cholecystectomy. Thus, increasing the demand for oxycodone hydrochloride to ensure the production of drugs that aid patients in effective management of postoperative pain.

Controlled Release Accounts for Significant Global Oxycodone Hydrochloride Market Share

The segment's growth can be attributed to the increasing utilization of controlled-release tablets for relieving severe to moderate persistent pain in situations where other forms of pain treatment solutions have been rendered ineffective. These products are also deployed in situations where continuous analgesics are required for an extended duration of time. The oxycodone hydrochloride-controlled release tablets are opioid analgesics that are orally administered and available in 20 mg and 10 mg strengths. The tablets contain various inactive ingredients including titanium dioxide, ammonio methacrylate copolymer, polyethylene glycol 400, sorbic acid, triacetin, sodium hydroxide, povidone, magnesium stearate, lactose, Hypromellose, talc, and stearyl alcohol. For instance, tablets with 20 mg strength also contain red iron oxide and polysorbate 80 and the tablet with 10 mg strength also contains hydroxypropyl cellulose. These controlled-release tablets are designed to ensure the controlled delivery of oxycodone over twelve hours. The release of oxycodone from these tablets is independent of pH and the oxycodone released from the tablets is absorbed at a bioavailability of 60%-87%. Thus, utilization of controlled-release tablets is boosting the segment's expansion and supporting the global oxycodone hydrochloride market growth.

Increased Product Requirement for Medicine Manufacturing Supports Market Expansion

The rising incidences of cancer and the increasing requirement for surgical procedures for the treatment and management of various health conditions is boosting the demand for oxycodone hydrochloride. This augmentation can be attributed to the effective pain management offered by the chemical in both minor surgical procedures and postoperative pain. The growing emphasis on patient care in various healthcare facilities is another major factor bolstering the requirement for oxycodone hydrochloride-based medication for effective management of severe and acute pain, propelling the expansion of the segment and boosting the global oxycodone hydrochloride market growth. The surge in the aging populace is another major factor supporting the growth of the segment as the older population is more susceptible to various pain-causing disorders and requires various surgical procedures to ensure proper management and treatment of various health conditions. For instance, according to a research article published by researchers from the Department of Urology and Department of Population Health Sciences, Geisinger, Danville, PA, approximately 4 million surgical procedures are performed every year in individuals aged 65 or older. Thus, bolstering the requirement for oxycodone hydrochloride for manufacturing medicine for the management of pain post-surgical procedures.

Future Market Scenario (2024-2031F)

According to the global oxycodone hydrochloride market analysis, various interventional studies are underway to evaluate the safety, efficacy, tolerability, and pharmacokinetic effects of oxycodone. For instance, Zuyderland Medisch Centrum is currently conducting a study to identify the impact of intercostal nerve cryoablation on the length of the postoperative hospital stay in comparison to the standard pain management of pectus excavatum patients. The randomized, single-center, unblinded, and prospective clinical trial is estimated to reach completion by September 2025. The increase in the number of such trials is propelling the requirement for oxycodone hydrochloride and aiding in evaluating the safety and efficacy of the chemical, thus increasing product applications and boosting the growth of the market.

Key Players Landscape and Outlook

The expansion of the market is supported by the rising investments by various companies in research and development activities. Furthermore, they are collaborating with other companies and organizations to support their R&D activities, which is expected to provide lucrative growth opportunities for the market. Various studies are conducted globally to evaluate the possible health benefits resulting from oxycodone hydrochloride.

For instance, OpalGenix, Inc., a developer of genetic tests for pain management and precision opioids is sponsoring an observational study to evaluate the effects of interactions and multiple genes on methadone and oxycodone's pharmacokinetics. The study is expected to conclude in September 2024. Such studies aid in determining the working and efficacy of the pain management solutions that deploy oxycodone hydrochloride, thus boosting the product demand and augmenting the market expansion.

1.Research Methodology

2.Project Scope & Definitions

3.Executive Summary

4.Voice of Customer

4.1.Market Awareness and Product Information
4.2.Brand Awareness and Loyalty
4.3.Factors Considered in Purchase Decision
- 4.3.1.Brand Name
- 4.3.2.Quality
- 4.3.3.Quantity
- 4.3.4.Price
- 4.3.5.Product Specification
- 4.3.6.Form Specification
- 4.3.7.Shelf Life
- 4.3.8.Availability of Product
4.4.Frequency of Purchase
4.5.Medium of Purchase

5.Global Oxycodone Hydrochloride Market Outlook, 2017-2031F

5.1.Market Size & Forecast
- 5.1.1.By Value
- 5.1.2.By Volume
5.2.By Purity
- 5.2.1.Less than 98%
- 5.2.2.98% to 99%
- 5.2.3.More than 99%
5.3.By Type
- 5.3.1.Immediate Release
- 5.3.2.Controlled Release
5.4.By Form
- 5.4.1.Solid
- 5.4.2.Liquid
5.5.By Application
- 5.5.1.Medicine Manufacturing
- 5.5.2.Research and Academics
- 5.5.3.Others
5.6.By Region
- 5.6.1.North America
- 5.6.2.South America
- 5.6.3.Europe
- 5.6.4.Asia-Pacific
- 5.6.5.Middle East & Africa
5.7.By Company Market Share (%), 2023

6.Global Oxycodone Hydrochloride Market Outlook, By Region, 2017-2031F

6.1.North America*
- 6.1.1.Market Size & Forecast
  - 6.1.1.1.By Value
  - 6.1.1.2.By Volume
- 6.1.2.By Purity
  - 6.1.2.1.Less than 98%
  - 6.1.2.2.98% to 99%
  - 6.1.2.3.More than 99%
- 6.1.3.By Type
  - 6.1.3.1.Immediate Release
  - 6.1.3.2.Controlled Release
- 6.1.4.By Form
  - 6.1.4.1.Solid
  - 6.1.4.2.Liquid
- 6.1.5.By Application
  - 6.1.5.1.Medicine Manufacturing
  - 6.1.5.2.Research and Academics
  - 6.1.5.3.Others
- 6.1.6.United States*
  - 6.1.6.1.Market Size & Forecast
  - 6.1.6.1.1.By Value
  - 6.1.6.1.2.By Volume
  - 6.1.6.2.By Purity
  - 6.1.6.2.1.Less than 98%
  - 6.1.6.2.2.98% to 99%
  - 6.1.6.2.3.More than 99%
  - 6.1.6.3.By Type
  - 6.1.6.3.1.Immediate Release
  - 6.1.6.3.2.Controlled Release
  - 6.1.6.4.By Form
  - 6.1.6.4.1.Solid
  - 6.1.6.4.2.Liquid
  - 6.1.6.5.By Application
  - 6.1.6.5.1.Medicine Manufacturing
  - 6.1.6.5.2.Research and Academics
  - 6.1.6.5.3.Others
- 6.1.7.Canada
- 6.1.8.Mexico

All segments will be provided for all regions and countries covered

6.2.Europe
- 6.2.1.Germany
- 6.2.2.France
- 6.2.3.Italy
- 6.2.4.United Kingdom
- 6.2.5.Russia
- 6.2.6.Netherlands
- 6.2.7.Spain
- 6.2.8.Turkey
- 6.2.9.Poland
6.3.Asia-Pacific
- 6.3.1.India
- 6.3.2.China
- 6.3.3.Japan
- 6.3.4.Australia
- 6.3.5.Vietnam
- 6.3.6.South Korea
- 6.3.7.Indonesia
- 6.3.8.Philippines
6.4.South America
- 6.4.1.Brazil
- 6.4.2.Argentina
6.5.Middle East & Africa
- 6.5.1.Saudi Arabia
- 6.5.2.UAE
- 6.5.3.South Africa

7.Supply Side Analysis

7.1.Capacity, By Company
7.2.Production, By Company
7.3.Operating Efficiency, By Company
7.4.Key Plant Locations (Up to 25)

8.Market Mapping, 2023

8.1.By Purity
8.2.By Type
8.3.By Form
8.4.By Application
8.5.By Region

9.Macro Environment and Industry Structure

9.1.Supply Demand Analysis
9.2.Import Export Analysis
9.3.Value Chain Analysis
9.4.PESTEL Analysis
- 9.4.1.Political Factors
- 9.4.2.Economic System
- 9.4.3.Social Implications
- 9.4.4.Technological Advancements
- 9.4.5.Environmental Impacts
- 9.4.6.Legal Compliances and Regulatory Policies (Statutory Bodies Included)
9.5.Porter's Five Forces Analysis
- 9.5.1.Supplier Power
- 9.5.2.Buyer Power
- 9.5.3.Substitution Threat
- 9.5.4.Threat from New Entrant
- 9.5.5.Competitive Rivalry

10.Market Dynamics

10.1.Growth Drivers
10.2.Growth Inhibitors (Challenges and Restraints)

11.Key Players Landscape

11.1.Competition Matrix of Top Five Market Leaders
11.2.Market Revenue Analysis of Top Five Market Leaders (in %, 2023)
11.3.Mergers and Acquisitions/Joint Ventures (If Applicable)
11.4.SWOT Analysis (For Five Market Players)
11.5.Patent Analysis (If Applicable)

12.Pricing Analysis

13.Case Studies

14.Key Players Outlook

14.1.Veranova Bidco, L.P.
- 14.1.1.Company Details
- 14.1.2.Key Management Personnel
- 14.1.3.Products & Services
- 14.1.4.Financials (As reported)
- 14.1.5.Key Market Focus & Geographical Presence
- 14.1.6.Recent Developments
14.2.Euroapi SA
14.3.Noramco, Inc.
14.4.Saneca Pharmaceuticals
14.5.Sun Pharmaceutical Industries Ltd.
14.6.Chattem Chemicals Inc.
14.7.Tiefenbacher API + Ingredients GmbH & Co. KG
14.8.Sigma-Aldrich (Merck Group)
14.9.Delphis Pharmaceutical India
14.10.PluviaEndo

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work

オキシコドン塩酸塩市場の評価：純度・タイプ・形態・用途・地域別の機会および予測 (2017-2031年)

Oxycodone Hydrochloride Market Assessment, By Purity, By Type, By Form, By Application, By Region, Opportunities and Forecast, 2017-2031F

目次

第1章調査手法

第2章プロジェクトの範囲と定義

第3章エグゼクティブサマリー

第4章顧客の声

第5章オキシコドン塩酸塩市場の展望

第6章オキシコドン塩酸塩市場の展望：地域別

第7章供給サイド分析

第8章市場マッピング

第9章マクロ環境と産業構造

第10章市場力学

第11章主要企業の情勢

第12章価格分析

第13章ケーススタディ

第14章主要企業の展望

第15章戦略的提言

第16章お問い合わせ・免責事項

List of Tables

List of Figures

Table of Contents

1.Research Methodology

2.Project Scope & Definitions

3.Executive Summary

4.Voice of Customer

5.Global Oxycodone Hydrochloride Market Outlook, 2017-2031F

6.Global Oxycodone Hydrochloride Market Outlook, By Region, 2017-2031F

7.Supply Side Analysis

8.Market Mapping, 2023

9.Macro Environment and Industry Structure

10.Market Dynamics

11.Key Players Landscape

12.Pricing Analysis

13.Case Studies

14.Key Players Outlook

15.Strategic Recommendations

16.About Us & Disclaimer

オキシコドン塩酸塩市場の評価：純度・タイプ・形態・用途・地域別の機会および予測 (2017-2031年)

Oxycodone Hydrochloride Market Assessment, By Purity, By Type, By Form, By Application, By Region, Opportunities and Forecast, 2017-2031F

目次

第1章 調査手法

第2章 プロジェクトの範囲と定義

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 オキシコドン塩酸塩市場の展望

第6章 オキシコドン塩酸塩市場の展望：地域別

第7章 供給サイド分析

第8章 市場マッピング

第9章 マクロ環境と産業構造

第10章 市場力学

第11章 主要企業の情勢

第12章 価格分析

第13章 ケーススタディ

第14章 主要企業の展望

第15章 戦略的提言

第16章 お問い合わせ・免責事項

List of Tables

List of Figures

Table of Contents

1.Research Methodology

2.Project Scope & Definitions

3.Executive Summary

4.Voice of Customer

5.Global Oxycodone Hydrochloride Market Outlook, 2017-2031F

6.Global Oxycodone Hydrochloride Market Outlook, By Region, 2017-2031F

7.Supply Side Analysis

8.Market Mapping, 2023

9.Macro Environment and Industry Structure

10.Market Dynamics

11.Key Players Landscape

12.Pricing Analysis

13.Case Studies

14.Key Players Outlook

15.Strategic Recommendations

16.About Us & Disclaimer

第1章調査手法

第2章プロジェクトの範囲と定義

第3章エグゼクティブサマリー

第4章顧客の声

第5章オキシコドン塩酸塩市場の展望

第6章オキシコドン塩酸塩市場の展望：地域別

第7章供給サイド分析

第8章市場マッピング

第9章マクロ環境と産業構造

第10章市場力学

第11章主要企業の情勢

第12章価格分析

第13章ケーススタディ

第14章主要企業の展望

第15章戦略的提言

第16章お問い合わせ・免責事項